BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Nishimura M. A successful treatment by hepatic arterial infusion therapy for advanced, unresectable biliary tract cancer. World J Hepatol 2010; 2(5): 192-197 [PMID: 21160995 DOI: 10.4254/wjh.v2.i5.192]
URL: https://www.wjgnet.com/1948-5182/full/v2/i5/192.htm
Number Citing Articles
1
JUNRO KATAOKA, HIDENORI SHIRAHA, SHIGERU HORIGUCHI, HIROAKI SAWAHARA, DAISUKE UCHIDA, TERUYA NAGAHARA, MASAYA IWAMURO, HIROKI MORIMOTO, YASUTO TAKEUCHI, KENJI KUWAKI, HIDEKI ONISHI, SHINICHIRO NAKAMURA, AKINOBU TAKAKI, KAZUHIRO NOUSO, TAKAHITO YAGI, KAZUHIDE YAMAMOTO, HIROYUKI OKADA. Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinomaOncology Reports 2016; 35(5): 2576 doi: 10.3892/or.2016.4681
2
Kanglian Zheng, Xiaodong Wang, Guang Cao, Liang Xu, Xu Zhu, Liqiang Fu, Shijie Fu, Haihui Cheng, Renjie Yang. Hepatic Arterial Infusion Chemotherapy with Oxaliplatin and 5-Fluorouracil for Advanced Gallbladder CancerCardioVascular and Interventional Radiology 2021; 44(2): 271 doi: 10.1007/s00270-020-02661-9